These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 24514954)

  • 1. PD-1(+) immune cell infiltration inversely correlates with survival of operable breast cancer patients.
    Sun S; Fei X; Mao Y; Wang X; Garfield DH; Huang O; Wang J; Yuan F; Sun L; Yu Q; Jin X; Wang J; Shen K
    Cancer Immunol Immunother; 2014 Apr; 63(4):395-406. PubMed ID: 24514954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The intratumoural subsite and relation of CD8(+) and FOXP3(+) T lymphocytes in colorectal cancer provide important prognostic clues.
    Ling A; Edin S; Wikberg ML; Öberg Å; Palmqvist R
    Br J Cancer; 2014 May; 110(10):2551-9. PubMed ID: 24675384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD8⁺ cytotoxic T cell and FOXP3⁺ regulatory T cell infiltration in relation to breast cancer survival and molecular subtypes.
    Liu F; Lang R; Zhao J; Zhang X; Pringle GA; Fan Y; Yin D; Gu F; Yao Z; Fu L
    Breast Cancer Res Treat; 2011 Nov; 130(2):645-55. PubMed ID: 21717105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive and prognostic factors in locally advanced breast cancer: effect of intratumoral FOXP3+ Tregs.
    Demir L; Yigit S; Ellidokuz H; Erten C; Somali I; Kucukzeybek Y; Alacacioglu A; Cokmert S; Can A; Akyol M; Dirican A; Bayoglu V; Sari AA; Tarhan MO
    Clin Exp Metastasis; 2013 Dec; 30(8):1047-62. PubMed ID: 23836289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory T lymphocyte infiltration in metastatic breast cancer-an independent prognostic factor that changes with tumor progression.
    Stenström J; Hedenfalk I; Hagerling C
    Breast Cancer Res; 2021 Feb; 23(1):27. PubMed ID: 33602289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential regulation and function of tumor-infiltrating T cells in different stages of breast cancer patients.
    Zhu S; Lin J; Qiao G; Xu Y; Zou H
    Tumour Biol; 2015 Sep; 36(10):7907-13. PubMed ID: 25953262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD8+ T cell infiltration in breast and colon cancer: A histologic and statistical analysis.
    Ziai J; Gilbert HN; Foreman O; Eastham-Anderson J; Chu F; Huseni M; Kim JM
    PLoS One; 2018; 13(1):e0190158. PubMed ID: 29320521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastatic triple-negative breast cancers at first relapse have fewer tumor-infiltrating lymphocytes than their matched primary breast tumors: a pilot study.
    Cimino-Mathews A; Ye X; Meeker A; Argani P; Emens LA
    Hum Pathol; 2013 Oct; 44(10):2055-63. PubMed ID: 23701942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Role of Tumoral PD-L1 and IDO1 Expression, and Intratumoral CD8+ and FoxP3+ Lymphocyte Infiltrates in 132 Primary Cutaneous Merkel Cell Carcinomas.
    Donizy P; Wu CL; Kopczynski J; Pieniazek M; Biecek P; Ryś J; Hoang MP
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The composition of T cell infiltrates varies in primary invasive breast cancer of different molecular subtypes as well as according to tumor size and nodal status.
    Glajcar A; Szpor J; Hodorowicz-Zaniewska D; Tyrak KE; Okoń K
    Virchows Arch; 2019 Jul; 475(1):13-23. PubMed ID: 31016433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of B7-H3, a potential factor of tumor immune evasion in combination with the number of regulatory T cells, affects against recurrence-free survival in breast cancer patients.
    Maeda N; Yoshimura K; Yamamoto S; Kuramasu A; Inoue M; Suzuki N; Watanabe Y; Maeda Y; Kamei R; Tsunedomi R; Shindo Y; Inui M; Tamada K; Yoshino S; Hazama S; Oka M
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4(Suppl 4):S546-54. PubMed ID: 24562936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential pattern and prognostic significance of CD4+, FOXP3+ and IL-17+ tumor infiltrating lymphocytes in ductal and lobular breast cancers.
    Droeser R; Zlobec I; Kilic E; Güth U; Heberer M; Spagnoli G; Oertli D; Tapia C
    BMC Cancer; 2012 Apr; 12():134. PubMed ID: 22471961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PD-L1 expression of the residual tumor serves as a prognostic marker in local advanced breast cancer after neoadjuvant chemotherapy.
    Chen S; Wang RX; Liu Y; Yang WT; Shao ZM
    Int J Cancer; 2017 Mar; 140(6):1384-1395. PubMed ID: 27925176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of infiltrating immune cell subtypes in invasive ductal carcinoma of the breast.
    Xu Y; Lan S; Zheng Q
    Tumori; 2018 Jun; 104(3):196-201. PubMed ID: 28430349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Implications of Tumor-Infiltrating Lymphocytes in Association With Programmed Death Ligand 1 Expression in Early-Stage Breast Cancer.
    Park IH; Kong SY; Ro JY; Kwon Y; Kang JH; Mo HJ; Jung SY; Lee S; Lee KS; Kang HS; Lee E; Joo J; Ro J
    Clin Breast Cancer; 2016 Feb; 16(1):51-8. PubMed ID: 26364145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunofluorescence-detected infiltration of CD4+FOXP3+ regulatory T cells is relevant to the prognosis of patients with endometrial cancer.
    Yamagami W; Susumu N; Tanaka H; Hirasawa A; Banno K; Suzuki N; Tsuda H; Tsukazaki K; Aoki D
    Int J Gynecol Cancer; 2011 Dec; 21(9):1628-34. PubMed ID: 21897268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer.
    Kim ST; Jeong H; Woo OH; Seo JH; Kim A; Lee ES; Shin SW; Kim YH; Kim JS; Park KH
    Am J Clin Oncol; 2013 Jun; 36(3):224-31. PubMed ID: 22495453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between radiotherapy-induced alteration of programmed death ligand 1 and survival in patients with uterine cervical cancer undergoing preoperative radiotherapy.
    Tsuchiya T; Someya M; Takada Y; Hasegawa T; Kitagawa M; Fukushima Y; Gocho T; Hori M; Nakata K; Hirohashi Y; Torigoe T; Saito T; Sakata KI
    Strahlenther Onkol; 2020 Aug; 196(8):725-735. PubMed ID: 31953603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of FOXP3+ tumor-infiltrating lymphocytes in breast cancer depends on estrogen receptor and human epidermal growth factor receptor-2 expression status and concurrent cytotoxic T-cell infiltration.
    Liu S; Foulkes WD; Leung S; Gao D; Lau S; Kos Z; Nielsen TO
    Breast Cancer Res; 2014 Sep; 16(5):432. PubMed ID: 25193543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-infiltrating lymphocytes, particularly the balance between CD8(+) T cells and CCR4(+) regulatory T cells, affect the survival of patients with oral squamous cell carcinoma.
    Watanabe Y; Katou F; Ohtani H; Nakayama T; Yoshie O; Hashimoto K
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 May; 109(5):744-52. PubMed ID: 20303300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.